| Product NDC: | 55154-0253 | 
| Proprietary Name: | Prevacid | 
| Non Proprietary Name: | lansoprazole | 
| Active Ingredient(s): | 30 mg/1 & nbsp; lansoprazole | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 55154-0253 | 
| Labeler Name: | Cardinal Health | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | NDA021428 | 
| Marketing Category: | NDA | 
| Start Marketing Date: | 20020830 | 
| Package NDC: | 55154-0253-0 | 
| Package Description: | 10 BLISTER PACK in 1 BAG (55154-0253-0) > 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK | 
| NDC Code | 55154-0253-0 | 
| Proprietary Name | Prevacid | 
| Package Description | 10 BLISTER PACK in 1 BAG (55154-0253-0) > 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK | 
| Product NDC | 55154-0253 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | lansoprazole | 
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 
| Route Name | ORAL | 
| Start Marketing Date | 20020830 | 
| Marketing Category Name | NDA | 
| Labeler Name | Cardinal Health | 
| Substance Name | LANSOPRAZOLE | 
| Strength Number | 30 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |